PCSK9 and stroke disorder: The prespecified analyses designed to assess the effect of PCSK9 inhibitors on stroke demonstrated a reduction in risk of ischemic stroke (IS) without increasing hemorrhagic stroke, irrespective of baseline LDL-C and of prior IS history (4, 5).